Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Jul;11(4):339-44.
doi: 10.1007/BF01982469.

Ro 21-7634, a new antiallergic agent with potent oral activity

R A Salvador, L B Czyzewski, H Baruth, A Hooper, A Medford, D Miller, T van Trabert, B Yaremko, A F Welton

Ro 21-7634, a new antiallergic agent with potent oral activity

R A Salvador et al. Agents Actions. 1981 Jul.

Abstract

Ro 21-7634 was examined for oral antiallergic activity in two in vivo models commonly used to evaluate antiallergics. In the rat PCA test, this drug had an oral ID50 of 1.14 mg/kg and was found to be more potent than several other antiallergics including Disodium Cromoglycate (cromoglycate), Oxatomide, Doxanthrazole, Xanoxate, 2,6-bis (ethyoxyoxalylamino) pyridine, PRD-92-EA and M + B 22,948. In contrast to cromoglycate, Ro 21-7634 was found to be an orally active inhibitor of antigen-induced broncho-constriction in passively sensitized rats (ID50 = 0.2 mg/kg). In addition, Ro 21-7634 inhibited antigen-induced histamine release in an in vivo passive peritoneal anaphylaxis test system, following intraperitoneal administration. Ro 21-7634 demonstrated no end organ antagonism toward histamine, metacholine or serotonin in the guinea pig.

PubMed Disclaimer

References

    1. J Med Chem. 1979 Jun;22(6):748-50 - PubMed
    1. Arch Int Pharmacodyn Ther. 1978 Apr;232(2):217-20 - PubMed
    1. Arzneimittelforschung. 1979;29(6):903-10 - PubMed
    1. Ann Intern Med. 1978 Aug;89(2):228-33 - PubMed
    1. J Med Chem. 1980 Jan;23(1):92-5 - PubMed